Alstrup, Lærke
Stryhn, Katrine
Riber, Claus
Hadad, Rakin
Hvistendahl, Jan
Tollund, Carsten
Haugaard, Steen B.
Funch-Jensen, Peter https://orcid.org/0009-0000-4991-4266
Article History
Received: 5 May 2023
Accepted: 8 July 2023
First Online: 24 July 2023
Declarations
:
: Ms. Lærke Alstrup, Ms. Katrine Stryhn, Dr. Claus Riber, Dr. Rakin Hadad, Dr. Jan Hvistendahl, Dr. Carsten Tollund, and Dr. Steen Bendix Haugaard have no conflicts of interest or financial ties to disclose. Dr. Peter Funch-Jensen has received research grants from Medtronic, Johnson&Johnson, and AstraZeneca. He also holds shares in Novo Nordisk A/S. This study received no funding.
: The study protocol and data used in this article were approved by the Danish Data Protection Agency. As the data were obtained from Aleris Hospitals’ clinical registries, they are considered quality assurance data according to Danish legislation and therefore not subject to approval from the Danish Scientific Ethics Committee.